NextPlat (NXPL) Free Cash Flow (2010 - 2026)
NextPlat's (NXPL) quarterly Free Cash Flow came in at $1.0 million in Q2 2026, up 193.3% year-over-year from $351179.7 in Q2 2025, and up 140.71% quarter-over-quarter from -$2.5 million in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Free Cash Flow (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Free Cash Flow for 15 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Free Cash Flow rose 193.3% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was -$4.6 million, a 44.87% increase from a year earlier, with the FY2025 full-year figure at -$6.2 million, down 9.69% from the prior year.
- Free Cash Flow was $1.0 million for Q2 2026 at NextPlat, up from -$2.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $2.2 million in Q2 2024 and troughed at -$4.7 million in Q3 2024.
- A 5-year average of -$1.2 million and a median of -$1.2 million in 2022 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 277.27% in 2024, down 261.44% in 2024.
- Over 5 years, Free Cash Flow stood at -$1.1 million in 2022, then surged by 141.41% to $462000.0 in 2023, then sank by 196.1% to -$444000.0 in 2024, then increased by 23.65% to -$339000.0 in 2025, then jumped by 403.83% to $1.0 million in 2026.
- The last three Free Cash Flow figures came in at $1.0 million (Q2 2026), -$2.5 million (Q1 2026), and -$339000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 307.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 329.00 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 26.40 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -51.94 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 593.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 53.62 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 8.08 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 42.73 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Mar 31, 2026 | -2.53 Mn |
| Dec 31, 2025 | -339,000.00 |
| Sep 30, 2025 | -2.73 Mn |
| Jun 30, 2025 | -1.10 Mn |
| Mar 31, 2025 | -2.03 Mn |
| Dec 31, 2024 | -444,000.00 |
| Sep 30, 2024 | -4.71 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | -2.75 Mn |
| Dec 31, 2023 | 462,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | -2.14 Mn |
| Dec 31, 2022 | -1.12 Mn |
| Sep 30, 2022 | -918,697.00 |
| Jun 30, 2022 | -1.35 Mn |
| Mar 31, 2022 | -936,555.00 |
| Dec 31, 2021 | -1.23 Mn |
| Sep 30, 2021 | -1.80 Mn |